J. Castillo

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

A. Belenguer, S. Gil-Perotín, B. Casanova, 2022, Journal of Neurology.

Oligoclonal M bands unveil occult inflammation in multiple sclerosis.

B. Casanova, L. Villar, F. Pérez-Miralles, 2022, Multiple sclerosis and related disorders.

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

A. Belenguer, S. Gil-Perotín, B. Casanova, 2022, Journal of Neurology.

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.

A. Zeiher, S. Dimmeler, F. Seeger, 2012, Journal of the American College of Cardiology.

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

B. Casanova, F. Gascón-Giménez, C. Alcalá, 2022, Frontiers in Neurology.

Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis.

C. Mohan, S. Wenderfer, K. Vanarsa, 2022, Rheumatology.

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.

A. Zeiher, S. Dimmeler, F. Seeger, 2012, Journal of the American College of Cardiology.